僑雄國際(00381.HK)發行3億股代價股份
格隆匯1月14日丨僑雄國際(00381.HK)公告,內容有關(其中包括)發行本金額為3000萬港元第二批承兑票據,作為收購事項部分代價。
於2020年1月14日,買方、賣方及擔保人訂立償付契據,據此,根據償付契據的條款及條件並在其規限下,賣方同意認購而公司同意按發行價每股第二批代價股份0.1港元配發及發行3億股股份,作為全數及最終清償未結算代價3000萬港元。於向賣方交付第二批代價股份時,賣方應同時向公司或買方退還無產權負擔的第二批承兑票據。
向買方或公司退還第二批承兑票據後,公司將立即註銷第二批承兑票據,且賣方及擔保人不得就第二批承兑票據提出任何索賠。發及發行第二批代價股份須待聯交所批准第二批代價股份上市及買賣後,方可作實。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.